Nectar Lifesciences

quarterly
yearly
ParticularsJun '22Sep '22Dec '22Mar '23Jun '23
Revenue403.02388.65344.13387.89394.12
Expenses375.91410.84357.46385.59373.91
EBITDA27.11-22.19-13.332.3020.21
EBIT12.41-36.98-28.11-12.554.88
Profit Before Tax6.11-32.47-17.561.503.06
Net Profit3.90-22.47-9.293.681.82
Financial Ratios
Operating Profit Margin6.73%-5.71%-3.88%0.59%5.13%
Net Profit Margin0.97%-5.78%-2.70%0.95%0.46%
Earning Per Share (Diluted)0.17-1.00-0.410.160.08
Dividends Per ShareNANANANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ